Skip to main content

Whitehead Biopsy-Standardization Study to Use Affy Chips

NEW YORK, Sept. 16 - The Whitehead Institute Center for Genome Research will use Affymetrix GeneChips in studies designed to standardize the collection and analysis of tumor-biopsy data, Affy said today.

 

Working with an undisclosed number of "clinical institutions," the Whitehead will "study sample collection from tissue biopsies, amplification, data collection, and analysis. ...," according to Affy.

 

The center believes that "standardization will ensure" that expression data will be "comparable" by scientists who currently use DNA chips in their cancer research.

 

It was not immediately clear when the study will begin, but Affy said data from the research will eventually be published.

 

Click here for more information.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.